Effectdossier · gearchiveerd kwartaal
SLNO
Soleno Therapeutics, Inc. · Healthcare · Biotechnology
15Gevolgde houders
-1Δ houders
21.84MGehouden aandelen
$1.83BGerapporteerde waarde
+1Nieuwe posities
−2Uitstappen
Momentum-inputs (vergelijkbare managers):
breedte van houders -6.2% ·
aandelenstroom -0.7% ·
netto nieuwe posities -6.7%
— formule
Brede distributie — dalende aandelen en minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
Eigendom in de tijd
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q1 2026 | 81 | -6 | 38.38M | $1.28B | +6 | −12 |
| Q4 2025 | 86 | 0 | 43.97M | $2.04B | +1 | −1 |
| Q3 2025 | 17 | -1 | 29.19M | $1.97B | — | −1 |
| Q2 2025 | 15 | -1 | 21.84M | $1.83B | +1 | −2 |
| Q1 2025 | 13 | +4 | 13.32M | $951.87M | +4 | — |
| Q4 2024 | 9 | 0 | 8.99M | $404.33M | — | — |
| Q3 2024 | 8 | 0 | 6.39M | $322.73M | +2 | −2 |
| Q2 2024 | 8 | — | 4.85M | $197.82M | — | — |
Wie het bezit · Q2 2025
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Adage Capital Partners ✦ | 3.58M | -18.6% | $299.59M | 0.5% | ▼ Trim | 5 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 3.46M | +44.2% | $290.00M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 3.46M | +44.2% | $290.00M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 4 | Fidelity (FMR) ✦ | 3.34M | — | $279.65M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Fidelity (FMR) ✦ | 3.34M | — | $279.65M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Fidelity (FMR) ✦ | 3.34M | — | $279.65M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Fidelity (FMR) ✦ | 3.34M | — | $279.65M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Fidelity (FMR) ✦ | 3.34M | — | $279.65M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 2.84M | — | $238.33M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 2.84M | — | $238.33M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passief) | 2.84M | — | $238.33M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passief) | 2.84M | — | $238.33M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (passief) | 2.84M | — | $238.33M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (passief) | 2.84M | — | $238.33M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (passief) | 2.84M | — | $238.33M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (passief) | 2.84M | — | $238.33M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | BlackRock ✦ (passief) | 2.84M | — | $238.33M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | BlackRock ✦ (passief) | 2.84M | — | $238.33M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | BlackRock ✦ (passief) | 2.84M | — | $238.33M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | BlackRock ✦ (passief) | 2.84M | — | $238.33M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | BlackRock ✦ (passief) | 2.84M | — | $238.33M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | BlackRock ✦ (passief) | 2.84M | — | $238.33M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | The Vanguard Group ✦ (passief) | 2.49M | — | $208.43M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | The Vanguard Group ✦ (passief) | 2.49M | — | $208.43M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | The Vanguard Group ✦ (passief) | 2.49M | — | $208.43M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | The Vanguard Group ✦ (passief) | 2.49M | — | $208.43M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | The Vanguard Group ✦ (passief) | 2.49M | — | $208.43M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Citadel Advisors ✦ | 1.51M | -4.5% | $126.10M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 29 | Citadel Advisors ✦ | 1.51M | -4.5% | $126.10M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 30 | State Street Global Advisors ✦ (passief) | 1.40M | +20.2% | $117.71M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 31 | Geode Capital Management ✦ (passief) | 902.40K | +46.6% | $75.61M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 32 | Geode Capital Management ✦ (passief) | 902.40K | +46.6% | $75.61M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 33 | Millennium Management ✦ | 633.72K | -6.7% | $53.09M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 34 | Wellington Management ✦ | 621.04K | -10.5% | $52.03M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 35 | Wellington Management ✦ | 621.04K | -10.5% | $52.03M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 36 | Wellington Management ✦ | 621.04K | -10.5% | $52.03M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 37 | Wellington Management ✦ | 621.04K | -10.5% | $52.03M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 38 | Wellington Management ✦ | 621.04K | -10.5% | $52.03M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 39 | Wellington Management ✦ | 621.04K | -10.5% | $52.03M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 40 | Wellington Management ✦ | 621.04K | -10.5% | $52.03M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 41 | Capital World Investors ✦ | 614.83K | +32.3% | $51.51M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 42 | Marshall Wace ✦ | 288.33K | +133.0% | $24.16M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 43 | Marshall Wace ✦ | 288.33K | +133.0% | $24.16M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 44 | D. E. Shaw & Co. ✦ | 114.69K | +587.9% | $9.61M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 45 | Renaissance Technologies ✦ | 45.20K | Nieuw | $3.79M | 0.0% | New | 1 | SEC ↗ |
| 46 | AQR Capital Management ✦ | 3.66K | +17.4% | $306,300 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 47 | AQR Capital Management ✦ | 3.66K | +17.4% | $306,300 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 48 | AQR Capital Management ✦ | 3.66K | +17.4% | $306,300 | 0.0% | ▲ Add | 4 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Renaissance Technologies | $3.79M | 0.0% |
Verlaten
| Point72 Asset Management | $65.45M | was 0.2% |
| Soros Fund Management | $19.34M | was 0.5% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 224 houders, 55.22M aandelen, $1.81B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Vaak gezamenlijk in bezit
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Herkomst: Eigendom op basis van geparseerde 13F common-stockposities (gevolgde universum, vergelijkbare sets voor wijzigingen); insider-rijen afkomstig van formulieren 3/4/5; belangen uit Schedules 13D/13G; elke indiening verwijst naar het origineel op SEC EDGAR.
Rapportageperiode: Q2 2025 ·
Methodologie ·
Verkrijg dit via de API